low-dose radiation, cancer risk, mice, Berkeley National Laboratory, therapy, CT

Scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory  have uncovered new clues about the risk of cancer from low-dose radiation. In this research, low-dose is defined as equivalent to 100 millisieverts or roughly the dose received from 10 full-body computed tomography (CT) scans.

TomTec Imaging Systems GmbH announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the latest version of its TomTec-Arena software solution.

Fujifilm Medical Systems U.S.A. Inc. showcased the Aspire Cristalle at the 25th Annual Interdisciplinary Breast Center Conference sponsored by the National Consortium of Breast Centers, March 14-18 in Las Vegas.

Biotronik announced that the U.S. Food and Drug Administration (FDA) has approved its ProMRI Eluna pacemaker system. Biotronik ProMRI technology allows patients to undergo full-body magnetic resonance imaging (MRI) scans with both single-chamber (SR-T) and dual-chamber (DR-T) Eluna pacemakers when implanted with Setrox pacing leads.

The sixth Image Wisely Radiation Safety Case —Optimizing Radiation Use During a Difficult IVC Filter Retrieval — is now available to help radiologists, imaging technologists and medical physicists to assess their understanding of important radiation safety concepts — including dose monitoring and optimization. This is the latest in a series of free, online and mobile-compatible Image Wisely educational offerings, developed with the assistance of the American College of Radiology (ACR).

Green tea's popularity has grown quickly in recent years. Its fans can drink it, enjoy its flavor in their ice cream and slather it on their skin with lotions infused with it. Now, the tea could have a new, unexpected role -- to improve the image quality of MRIs. Scientists report in the journal ACS Applied Materials & Interfaces that they successfully used compounds from green tea to help image cancer tumors in mice.

Researchers from Banner Alzheimer's Institute (BAI) have developed a new brain image analysis method to better track the progression of beta-amyloid plaque deposition, a characteristic brain abnormality in Alzheimer's disease, according to a study published in the March issue of the Journal of Nuclear Medicine. Investigators also believe this new approach may make it easier to evaluate investigational anti-amyloid treatments in clinical trials.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now